Combination Therapy for Patients with Type 2 Diabetes: Repaglinide in Combination with Metformin

Robert G Moses


Expert Rev Endocrinol Metab. 2010;5(3):331-342. 

In This Article

Regulatory Affairs

In June 2008, repaglinide and metformin HCl (PrandiMet®) was approved by the FDA. This is the first and only FDC tablet of repaglinide and metformin for the treatment of T2DM.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.